HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)

A neurological condition that is characterized by uncontrolled rapid irregular movements of the eye (OPSOCLONUS) and the muscle (MYOCLONUS) causing unsteady, trembling gait. It is also known as dancing eyes-dancing feet syndrome and is often associated with neoplasms, viral infections, or autoimmune disorders involving the nervous system.
Also Known As:
Kinsbourne Syndrome; Dancing Eyes, Dancing Feet Syndrome; Dancing Eyes-Dancing Feet Syndrome; Opsoclonus Myoclonus Ataxia; Dancing Eyes Dancing Feet Syndrome; Opsoclonus Myoclonus Syndrome; Paraneoplastic Opsoclonus Myoclonus Ataxia; Paraneoplastic Opsoclonus-Myoclonus Ataxia
Networked: 146 relevant articles (7 outcomes, 9 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neuroblastoma
2. Nervous System Diseases (Neurological Disorders)
3. Infantile Spasms (West Syndrome)
4. Seizures (Seizure)
5. Neoplasms (Cancer)

Experts

1. Pranzatelli, Michael R: 20 articles (01/2014 - 11/2002)
2. Tate, Elizabeth D: 20 articles (01/2014 - 11/2002)
3. Blaes, Franz: 8 articles (12/2015 - 04/2002)
4. Travelstead, Anna L: 8 articles (06/2012 - 01/2005)
5. Colliver, Jerry A: 6 articles (05/2013 - 10/2008)
6. Blaes, F: 6 articles (05/2009 - 11/2003)
7. Verhulst, Steven J: 5 articles (01/2014 - 01/2010)
8. Darnell, Robert B: 5 articles (07/2011 - 07/2003)
9. Kaps, M: 5 articles (05/2009 - 11/2003)
10. Preissner, Klaus T: 4 articles (12/2015 - 08/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Opsoclonus-Myoclonus Syndrome:
1. Adrenocorticotropic Hormone (ACTH)FDA Link
2. rituximab (Mabthera)FDA Link
3. Intravenous Immunoglobulins (IVIG)FDA Link
4. SteroidsIBA
5. Dexamethasone (Maxidex)FDA LinkGeneric
6. Clonazepam (Rivotril)FDA LinkGeneric
7. AntibodiesIBA
8. gabapentin (Neurontin)FDA LinkGeneric
9. Oligoclonal BandsIBA
10. ChemokinesIBA

Therapies and Procedures

1. Plasmapheresis
2. Combined Modality Therapy
3. Immunotherapy
4. Immunomodulation
5. Aftercare (After-Treatment)